Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,295 | 61 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $533.73 | 25 | $0 (2022) |
| Amarin Pharma Inc. | $210.65 | 10 | $0 (2021) |
| AbbVie Inc. | $74.36 | 3 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $71.19 | 4 | $0 (2021) |
| GlaxoSmithKline, LLC. | $67.44 | 3 | $0 (2019) |
| Allergan, Inc. | $64.28 | 3 | $0 (2020) |
| Novo Nordisk Inc | $52.72 | 3 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $40.72 | 2 | $0 (2020) |
| Roche Diagnostics Corporation | $40.38 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $26.91 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.01 | 1 | Exact Sciences Corporation ($23.01) |
| 2022 | $73.74 | 3 | Janssen Pharmaceuticals, Inc ($26.91) |
| 2021 | $351.15 | 16 | PFIZER INC. ($137.44) |
| 2020 | $414.16 | 19 | PFIZER INC. ($186.78) |
| 2019 | $168.94 | 7 | Amarin Pharma Inc. ($45.43) |
| 2018 | $142.13 | 8 | PFIZER INC. ($104.93) |
| 2017 | $122.22 | 7 | PFIZER INC. ($56.39) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Oncology | ||||||
| 10/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/30/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: VACCINES | ||||||
| 11/02/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/15/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Gastroenterology | ||||||
| 09/07/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/20/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardiovascular | ||||||
| 06/28/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/12/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Cardiovascular | ||||||
| 05/04/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Diabetes | ||||||
| 04/07/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Gastroenterology | ||||||
| 03/16/2021 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: VACCINES | ||||||
| 03/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: ANALGESIC | ||||||
| 02/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiovascular | ||||||
| 02/02/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/22/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/07/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Cardiovascular | ||||||
| 11/12/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Cardiovascular | ||||||
| 11/10/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $30.11 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/05/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 343 | 561 | $126,102 | $45,348 |
| 2022 | 12 | 915 | 1,900 | $420,118 | $172,509 |
| 2021 | 12 | 489 | 1,138 | $189,826 | $82,818 |
| 2020 | 10 | 530 | 1,359 | $174,626 | $83,618 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 156 | $50,700 | $14,075 | 27.8% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 48 | 111 | $23,310 | $8,275 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 51 | 51 | $15,300 | $7,158 | 46.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 14 | 59 | $8,673 | $4,705 | 54.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 50 | 78 | $7,410 | $3,989 | 53.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 25 | $10,625 | $3,483 | 32.8% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 35 | 61 | $8,784 | $3,436 | 39.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 20 | $1,300 | $227.88 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 226 | 455 | $147,592 | $49,050 | 33.2% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 79 | 372 | $81,468 | $38,602 | 47.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 123 | 123 | $36,900 | $17,657 | 47.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 121 | 230 | $21,850 | $15,456 | 70.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 83 | 93 | $39,335 | $13,399 | 34.1% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 53 | 154 | $23,870 | $11,942 | 50.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 48 | 234 | $26,910 | $10,700 | 39.8% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 32 | 70 | $14,700 | $7,435 | 50.6% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 30 | 30 | $9,750 | $2,966 | 30.4% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 27 | 27 | $9,450 | $2,948 | 31.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 28 | 43 | $3,827 | $1,533 | 40.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 65 | 69 | $4,466 | $821.21 | 18.4% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2021 | 62 | 301 | $46,655 | $19,440 | 41.7% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2021 | 61 | 145 | $31,755 | $16,902 | 53.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 42 | 222 | $25,530 | $10,152 | 39.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 87 | $28,143 | $9,768 | 34.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 92 | 176 | $16,720 | $9,722 | 58.1% |
About Dr. Lillian Ngaw, M.D
Dr. Lillian Ngaw, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154373538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lillian Ngaw, M.D has received a total of $1,295 in payments from pharmaceutical and medical device companies, with $23.01 received in 2023. These payments were reported across 61 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,295).
As a Medicare-enrolled provider, Ngaw has provided services to 2,277 Medicare beneficiaries, totaling 4,958 services with total Medicare billing of $384,294. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pasadena, CA
- Active Since 05/16/2006
- Last Updated 04/21/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1154373538
Products in Payments
- Vascepa (Drug) $210.65
- CHANTIX (Drug) $161.59
- ELIQUIS (Drug) $122.56
- UBRELVY (Drug) $117.36
- XIFAXAN (Drug) $82.51
- EUCRISA (Drug) $79.88
- SHINGRIX (Biological) $67.44
- LYRICA (Drug) $55.99
- VIAGRA (Drug) $41.15
- AUSTEDO (Drug) $40.72
- RS Harmony Test Related Products (Device) $40.38
- PREVNAR 13 (Biological) $33.89
- XARELTO (Drug) $26.91
- PREVNAR 20 (Biological) $23.43
- ENTRESTO (Drug) $23.40
- Cologuard Collection Kit (Device) $23.01
- Ozempic (Drug) $21.87
- CREON (Drug) $21.28
- NAPRELAN (Drug) $18.54
- Levemir (Drug) $17.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882